A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5575 (2006.01) A61K 38/00 (2006.01) A61K 45/00 (2006.01) A61P 31/04 (2006.01) A61P 31/10 (2006.01) A61P 31/12 (2006.01) A61P 31/18 (2006.01) A61P 31/20 (2006.01) A61P 31/22 (2006.01) A61P 33/10 (2006.01) A61P 33/12 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 37/04 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2684922
Disclosed is a substance which has a low molecular weight, can be applied in a simpler manner, and has an immunopotentiating activity against cancer and/or a microorganism-mediated infectious disease. An EP4 agonist exhibits an immunopotentiating activity through the activation of a cytotoxic T cell, and is therefore useful for the prevention and/or treatment of cancer or a microorganism-mediated infectious disease.
La présente invention concerne une substance avec un faible poids moléculaire, qui peut être utilisée de manière simple et qui possède une activité immunostimulante contre le cancer et/ou une maladie infectieuse due à un microorganisme. Un agoniste EP4 exhibe une activité immunostimulante à travers l'activité d'une cellule T cytotoxique et est par conséquent utile pour la prévention et/ou le traitement du cancer ou d'une maladie infectieuse due à un microorganisme.
Kabashima Kenji
Kanaji Toshiya
Maruyama Takayuki
Seo Naohiro
Takigawa Masahiro
National University Corporation Hamamatsu University School Of Medicine
Ono Pharmaceutical Co. Ltd.
Riches Mckenzie & Herbert Llp
LandOfFree
Cytotoxic t cell activator comprising ep4 agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic t cell activator comprising ep4 agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic t cell activator comprising ep4 agonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499365